Global Valsartan Market Size, Share & Trend Analysis- By Type, By Application Regional Outlook, Competitive Tactics, and Segment Forecast to 2031

The Global Valsartan Market size was estimated at USD XX billion in 2020 and is expected to hit around USD XX billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030.

Global Valsartan Market: Breakup by Region, 2022 & 2031

Diagram Description automatically generated with low confidence

Source: Primary Research and Secondary Research Analysis

Valsartan is a drug utilized for treating hypertension and heart failure. It is categorized as an angiotensin II receptor blocker (ARB) and functions by dilating blood vessels to aid in decreasing blood pressure and enhancing blood circulation. In certain instances, Valsartan may be prescribed to minimize the likelihood of heart attack or stroke in patients with a cardiovascular disease background. It is typically taken orally as a pill or capsule and may be recommended on its own or in combination with other medications.

The global market for valsartan pertains to the market of the drug used to cure hypertension and heart failure. This medicine is classified as an angiotensin II receptor blocker (ARB) and its function is to relax blood vessels and boost blood flow, ultimately reducing blood pressure. The global valsartan market comprises of the sales of the medication in different forms, such as tablets and capsules, and is divided by geographical regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Due to the escalating number of hypertension and cardiovascular diseases cases worldwide, the market is anticipated to experience significant growth in the upcoming years.

Global Valsartan Market Research Report, 2020-2031

Table of Contents

  1. 1. Introduction
    1. Report description
    2. Key market segments
    3. Regional Scope
    4. Executive Summary
  2. 2. Research Methodology
    1. Secondary Research
    2. Primary Research
    3. Secondary Analyst Tools and Models
  3. 3. Market Dynamics
    1. Market driver analysis
    2. Market restraint analysis
    3. Market Opportunity    
    4. Market Challenges
    5. Impact analysis of COVID-19 on the Valsartan Market
  4. 4. Market Variables and Outlook
    1. SWOT Analysis
      1. Strengths
      2. Weaknesses
      3. Opportunities
      4. Threats
    2. Supply Chain Analysis
    3. PESTEL Analysis
      1. Political Landscape
      2. Economic Landscape
      3. Social Landscape
      4. Technological Landscape
      5. Environmental Landscape
      6. Legal Landscape
    4. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitute
      4. Threat of New Entrant
      5. Competitive Rivalry
  5. 5. Valsartan Market: Type Estimates & Trend Analysis
    1. Valsartan Market value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. 40 mg Tablets
      1. Market Size & Forecast, 2020-2031
    4. 80 mg Tablets
      1. Market Size & Forecast, 2020-2031
    5. 160 mg Tablets
      1. Market Size & Forecast, 2020-2031
    6. 320 mg Tablets
      1. Market Size & Forecast, 2020-2031

 

  1. 6. Valsartan Market: Application Estimates & Trend Analysis
    1. Valsartan Market value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. Hypertension
      1. Market Size & Forecast, 2020-2031
    4. Heart Failure
      1. Market Size & Forecast, 2020-2031
    5. Heart Attack
      1. Market Size & Forecast, 2020-2031

 

  1. 7. Valsartan Market: Regional Estimates & Trend Analysis
    1. Valsartan Market value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. North America
      1. Market Size & Forecast, 2020-2031
    4. Europe
      1. Market Size & Forecast, 2020-2031
    5. Asia Pacific
      1. Market Size & Forecast, 2020-2031
    6. Middle East & Africa
      1. Market Size & Forecast, 2020-2031
    7. Latin America
      1. Market Size & Forecast, 2020-2031
  2. 8. Valsartan Market: Country Estimates & Trend Analysis
    1. Valsartan Market value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. U.S.
      1. Market Size & Forecast, 2020-2031
    4. Canada
      1. Market Size & Forecast, 2020-2031
    5. Mexico
      1. Market Size & Forecast, 2020-2031
    6. UK
      1. Market Size & Forecast, 2020-2031
    7. France
      1. Market Size & Forecast, 2020-2031
    8. Germany
      1. Market Size & Forecast, 2020-2031
    9. Russia
      1. Market Size & Forecast, 2020-2031
    10. Italy
      1. Market Size & Forecast, 2020-2031
    11. Spain
      1. Market Size & Forecast, 2020-2031
    12. China
      1. Market Size & Forecast, 2020-2031
    13. India
      1. Market Size & Forecast, 2020-2031
    14. Japan
      1. Market Size & Forecast, 2020-2031
    15. Indonesia
      1. Market Size & Forecast, 2020-2031
    16. South Korea
      1. Market Size & Forecast, 2020-2031
    17. Australia
      1. Market Size & Forecast, 2020-2031
    18. Brazil
      1. Market Size & Forecast, 2020-2031
    19. Argentina
      1. Market Size & Forecast, 2020-2031
    20. Saudi Arabia
      1. Market Size & Forecast, 2020-2031
    21. UAE
      1. Market Size & Forecast, 2020-2031
    22. South Africa
      1. Market Size & Forecast, 2020-2031
  3. 9. Competitive Landscape
    1. Company Market Share Analysis
    2. Vendor Landscape
    3. Competition Dashboard
  4. 10. Company Profiles
    1. Business Overview, Product Landscape, Financial Performance and Company Strategies for below companies
    2. Novartis
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    3. Sun Pharmaceutical
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    4. Teva
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    5. Mylan
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    6. Alembic Pharmaceuticals
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    7. Lupin
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    8. Aurobindo Pharma
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    9. Macleods Pharmaceuticals
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    10. HETERO
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    11. Torrent Pharmaceuticals
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    12. Huaren Pharmaceuticals
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    13. Jubilant Pharma
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    14. Amneal Pharmaceuticals
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprints
      5. Strategic Initiatives
    15. Zhejiang Huahai Pharmaceuticals
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprints
      5. Strategic Initiatives
    16. Square Pharmaceuticals
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprints
      5. Strategic Initiatives
    17. Unichem Labroratories
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprints
      5. Strategic Initiatives

 

  1. 11. Conclusion


In case you don’t find what, you are looking for, please get in touch with our custom research team at sales@organicmarketresearch.com or Download Free Sample Report

  • Buy Now

Speak To Consultant

or Face to Face Meeting

Why Choose Us

  • 24x7 Post-Sales Support
  • 4000+ Reports Repository
  • 10% Free Customization
  • Large Network Of Industry Experts
  • Deep Sector Specific Intelligence
  • Unique Mix Of Global, Regional And Country Specific Reports

Related Reports

Recent News

Why Buy From Us?

Succeed

Our reports with in-depth insights will equip you to succeed in your business plans.

Instant Access

Get instant access to the information you need to make the right decision.

Opportunities

Explore where opportunities lie for you and mitigate the risks.

Trusted

We are one of the most trusted brands setting benchmarks of excellence.